Insights

The time to start planning your roadmap to commercial quantum adoption is now. Where to start? Read our exclusive report.

Emerging deep tech like biotechnology and synthetic biology are shaping an exciting new bioeconomy. This CC Innovation Briefing offers a vision for its future, and explains how scalable, profitable and resilient bioprocesses will benefit businesses and sustainability.

Resisting automation is no longer an option – so the attention of the world’s C-Suite is turning from the question of ROI to three fundamentals… what kind of robotics and automation should I pursue, how can automation make my business more resilient, and how do I make my business ready for automation, autonomy and their successful scaling?

This paper outlines our concept of ‘evolved intent-based networks’ – utilising pervasive intelligence from across an entire communications network to automate configuration that supports a specific set business of requirements. The ability to assure a specific service and experience level offers huge opportunities.

One of the potentially most transformative challenges we face as deep tech innovators is building empathy into AI-enabled human-machine interactions. So, what is an empathetic machine and why is it important for business and society to build empathetic AI into human-interactive systems? 

Businesses are committed to sustainability and net zero targets. Regenerative agriculture has a huge role to play to help meet these targets and reduce environmental impact, but it will only be successfully adopted at scale if there is trust and traceability in the measurement data.

Now is an exciting time to be working in the medtech industry, says John Genova, who heads our smart active implants teams. Here, John explains why the next medical frontier is smart active implants.

CC is collaborating with telecommunications multinational Vodafone on an exciting project that supports the ambitions of the UN’s Global Biodiversity Framework for businesses. A technology solution is being developed to tackle conflict when humans and wildlife coexist in close proximity.

Technology innovations are now able to start realising health concepts that have been talked about for years. As Stephanie Mou explains, insurmountable market advantage awaits the organisation that can establish a compelling delivery platform over the next five years… 

Adopting a private network can be game-changing in enabling greater productivity, flexibility and differentiation for enterprises with complex and demanding needs, but where to start? In this Innovation Briefing, we explore the emerging drivers for private network adoption and the key considerations of vendors and enterprises when developing technologies for demanding use cases.

Precision medicine, driven by remarkable deep tech innovation, is leading to transformative patient treatments – but we mustn’t leave patients with rare diseases behind. Here Symon Cotton calls for collaboration to ensure that solutions are found, for the benefit of patients and industry.

Roswell and CC collaborated to develop the world’s first molecular electronics chip for healthcare diagnostics. Roswell has ‘digitised biology’ enabling a sample to be placed on a chip that can run multiple tests, transforming the diagnostics industry from one-test-one-result to one-test-many-results.